1 results match your criteria: "et Centre de reference des maladies rares d'origine hypophysaires DEFHY[Affiliation]"
Merits and pitfalls of mifepristone in Cushing's syndrome.
Eur J Endocrinol
June 2009
Service d'Endocrinologie, diabète et maladies métaboliques, et Centre de reference des maladies rares d'origine hypophysaires DEFHY, Hôpital de la Timone, Marseille 13005, France.
Objective: Mifepristone is the only available glucocorticoid receptor antagonist. Only few adult patients with hypercortisolism were treated to date by this drug. Our objective was to determine effectiveness and tolerability of mifepristone in Cushing's syndrome (CS).
View Article and Find Full Text PDF